Extendicare Inc. (TSX:EXE)
Canada · Delayed Price · Currency is CAD | Market Cap | 2.64B +96.3% |
| Revenue (ttm) | 1.98B +31.1% |
| Net Income | 121.28M +45.8% |
| EPS | 1.31 +37.4% |
| Shares Out | 95.05M |
| PE Ratio | 21.10 |
| Forward PE | 18.04 |
| Dividend | 0.53 (1.91%) |
| Ex-Dividend Date | Oct 30, 2026 |
| Volume | 344,362 |
| Open | 27.67 |
| Previous Close | 27.72 |
| Day's Range | 27.29 - 28.15 |
| 52-Week Range | 15.64 - 39.14 |
| Beta | 1.07 |
| Analysts | Strong Buy |
| Price Target | 38.94 (+40.43%) |
| Earnings Date | Nov 5, 2026 |
About Extendicare
Extendicare Inc. operates across Canada, delivering a wide array of vital care and support services specifically designed for the senior population through its various subsidiaries. The company's diverse service portfolio includes long-term care facilities, a range of retirement living options, and comprehensive home-based health services. These home health offerings span professional nursing care, various rehabilitative therapies (including occupational, physical, and speech therapy), and assistance with everyday activities. Additionally, Exte... [Read more]
Financial Performance
In 2025, Extendicare's revenue was 1.66 billion, an increase of 13.25% compared to the previous year's 1.47 billion. Earnings were 96.66 million, an increase of 28.52%.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for EXE stock is "Strong Buy." The 12-month stock price target is $38.94, which is an increase of 40.43% from the latest price.
News
Extendicare Announces October 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - October 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the ...
Extendicare Announces Timing of 2026 Third Quarter Results and Conference Call
Markham, Ontario--(Newsfile Corp. - October 5, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced today that it plans to release its financial results for the third quarter...
Extendicare Announces September 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - September 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of th...
Extendicare Slides: Investor presentation
Extendicare has posted slides in relation to its latest quarterly earnings report, which was published on September 9, 2026.
“Make a real offer, or pick an arbitrator” - CUPE holds province-wide day of action to call out delays in negotiations with Extendicare
Markham, ON--(BUSINESS WIRE)--For months, 8 CUPE locals representing over 1100 Long-Term Care workers across Ontario have been kept waiting for a fair contract. Where other workers would have been abl...
Care Can't Wait! Long-Term Care workers hold province wide day of action calling out delays in contract negotiations with Extendicare
OTTAWA--(BUSINESS WIRE)--For months, 8 CUPE locals representing over 1100 long term care workers across Ontario have been kept waiting for a fair contract. Where other workers would have been able to ...
CUPE members take action to demand a fair deal from Extendicare
Sudbury, ON--(BUSINESS WIRE)--CUPE 1182, one of 8 CUPE locals participating in the Extendicare Central Table bargaining held a rally in Sudbury today. The union representing workers at Extendicare Yor...
Extendicare price target raised to C$39 from C$38 at RBC Capital
RBC Capital raised the firm’s price target on Extendicare (EXETF) to C$39 from C$38 and keeps an Outperform rating on the shares.
Extendicare price target raised to C$40 from C$38 at CIBC
CIBC raised the firm’s price target on Extendicare (EXETF) to C$40 from C$38 and keeps an Outperformer rating on the shares.
Extendicare Earnings Call Transcript: Q2 2026
Q2 2026 saw revenue surge 59.4% and adjusted EBITDA rise 71%, driven by major acquisitions and robust organic growth. Home health care volumes more than doubled, while new capital structure improved leverage and flexibility. Integration of recent acquisitions is progressing, with synergy targets on track.
Extendicare Earnings release: Q2 2026
Extendicare released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
Extendicare MD&A: Q2 2026
Extendicare filed a regulatory document on August 7, 2026 disclosing important business information.
Extendicare Report: Q2 2026
Extendicare published a report on August 7, 2026 containing material business information for investors and shareholders.
Extendicare Slides: Q2 2026
Extendicare has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 7, 2026.
Extendicare Announces Timing of 2026 Second Quarter Results and Conference Call
Markham, Ontario--(Newsfile Corp. - July 7, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced today that it plans to release its financial results for the second quarter o...
Extendicare Slides: Investor presentation
Extendicare has posted slides in relation to its latest quarterly earnings report, which was published on May 31, 2026.
Extendicare price target raised to C$39 from C$32 at TD Securities
TD Securities raised the firm’s price target on Extendicare (EXETF) to C$39 from C$32 and keeps a Buy rating on the shares.
Extendicare price target raised to C$38 from C$32 at CIBC
CIBC raised the firm’s price target on Extendicare (EXETF) to C$38 from C$32 and keeps an Outperformer rating on the shares.
Extendicare Earnings Call Transcript: Q1 2026
Q1 2026 saw strong revenue and AFFO growth, driven by Home Healthcare volumes and acquisitions. The CBI acquisition and new unsecured notes enhanced scale and capital flexibility, while integration and deleveraging are near-term priorities.
Extendicare Earnings release: Q1 2026
Extendicare released its Q1 2026 earnings on May 8, 2026, summarizing the period's financial results.
Extendicare Slides: Q1 2026
Extendicare has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 8, 2026.
Extendicare Report: Q1 2026
Extendicare published a report on May 8, 2026 containing material business information for investors and shareholders.
Extendicare MD&A: Q1 2026
Extendicare filed a regulatory document on May 8, 2026 disclosing important business information.
CUPE's Extendicare Central Table Receives Overwhelming Mandate for Job Action if a Deal is not Reached
MARKHAM, ON.--(BUSINESS WIRE)--CUPE's Extendicare Central Bargaining table is holding strategic planning meetings in Markham this week, one month after negotiations ended with Extendicare. The eight C...
Extendicare initiated with a Buy at Desjardins
Desjardins initiated coverage of Extendicare (EXETF) with a Buy rating and C$34.50 price target The firm believes that Extendicare’s shift toward seniors care services, combined with an aging Canadian...